Sunil Krishnan MD

Physician

6400 Fannin St Ste 220Houston, TX 77030
Phone+1 713-704-2650
Fax+1 713-704-5710

Dr. Krishnan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Krishnan's full profile Already have an account?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 2000 - 2004
Geisinger Health System (Danville)Residency, Internal Medicine, 1997 - 2000
Christian Medical College VelloreClass of 1995

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2004 - 2027
FL State Medical License 2019 - 2024
MN State Medical License 2000 - 2004
PA State Medical License 1997 - 2000
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015

Clinical Trials

Proton Therapy and Bevacizumab for Primary Liver Tumors
TERMINATED
PHASE1
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
COMPLETED
PHASE1
Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer Start of enrollment: 2008 Aug 11
TERMINATED
PHASE2

Publications & Presentations

PubMed

Overcoming IGF1R-mediated resistance to oncolytic HSV1 and radiotherapy via triple combination therapy.
Alexandra A Miller, Min-Hye Noh, Jin Muk Kang, Jiyeon Kim, Lily Nguyen
Cell Death & Disease. 2026-07-17
4 citations
Comprehensive analysis of the tumor targeting efficiency of functionalized nanoparticles in an immunocompetent environment.
Nolan Jackson, Nasry Bouzeineddine, Daniel Cecchi, Safara Holder, Katrina Gee
Scientific Reports. 2025-10-09
1 citations
Impacts of Radiation on Metabolism and Vascular Cell Senescence.
Junichi Abe, Khanh Chau, Anahita Mojiri, Guangyu Wang, Masayoshi Oikawa
Antioxidants & Redox Signaling. 2025-07-01

Press Mentions

Space Medicine Team Reaches for the Stars to Cure DiseasesJuly 25th, 2025
At the Bedside: After Years of Mysterious Cardiac Episodes, a Patient Is Offered a New Lease on Life Through Innovative Multidisciplinary Techniques Championed at UTHealth HoustonJuly 22nd, 2025
“Indian American Cancer Scientists Honored with Prestigious Awards for Groundbreaking Discoveries”May 9th, 2025

Grant Support

In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapyUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
Rational translation of gold nanoparticle mediated radiosensitization to the clinicUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2021–2026
Rational translation of gold nanoparticle mediated radiosensitization to the clinicUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2021–2026
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticlesUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2023–2024